Clinical Research Directory
Browse clinical research sites, groups, and studies.
Familial Pancreatic Cancer PROPHilation Program in Italy
Sponsor: Associazione Italiana per lo Studio del Pancreas
Summary
The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only. Participants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test. Up to 3,000 participants will be enrolled in this study.
Official title: Standardised Genetic Profiling of Subjects Belonging to the Italian Multicenter Registry of Prospective Surveillance of Subjects at Genetic Risk of Pancreatic Cancer
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
3000
Start Date
2022-12-20
Completion Date
2028-12-20
Last Updated
2023-02-15
Healthy Volunteers
No
Interventions
Saliva swab testing
41 pancreatic cancer predisposition genes will be tested through a saliva-based swab
Locations (1)
Chirurgia generale e del Pancreas Azienda Ospedaliera Universitaria Integrata
Verona, Italy